Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis

Journal of Investigative Dermatology

Volumn 129, Issue 12, 2009, Pages 2805-2817

  Kim, Brian S ^a,b   Miyagawa, Fumi ^a   Cho, Young Hun ^a   Bennett, Clare L ^c,d   Clausen, Björn E ^c,d   Katz, Stephen I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; OVALBUMIN;

ADOPTIVE TRANSFER; ANIMAL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL COMMUNICATION; CELL LINE; CYTOLOGY; DERMIS; DRUG EFFECT; EPIDERMIS; GENE; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; KERATINOCYTE; LANGERHANS CELL; MOUSE; PATHOLOGY; TRANSGENIC MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL LINE; DERMIS; DIPHTHERIA TOXIN; EPIDERMIS; GENES, MHC CLASS II; GRAFT VS HOST DISEASE; KERATINOCYTES; LANGERHANS CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN;

EID: 79958086561     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.176     Document Type: Article

References (40)

1. Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR et al. (2003) Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301:1925-8
2. Azukizawa H, Kosaka H, Sano S, Heath WR, Takahashi I, Gao XH et al. (2003) Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol 33:1879-88
3. Bal V, McIndoe A, Denton G, Hudson D, Lombardi G, Lamb J et al. (1990) Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol 20:1893-7
4. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-52
5. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML et al. (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169:569-76
6. Bogunovic M, Ginhoux F, Wagers A, Loubeau M, Isola LM, Lubrano L et al. (2006) Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J Exp Med 203:2627-38
7. Breathnach SM, Katz SI (1983) Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease. J Immunol 131:2741-5
8. Breathnach SM, Shimada S, Kovac Z, Katz SI (1986) Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes. J Invest Dermatol 86:226-34
9. Carbone FR, Belz GT, Heath WR (2004) Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trends Immunol 25:655-8
10. Caughman SW, Sharrow SO, Shimada S, Stephany D, Mizuochi T, Rosenberg AS et al. (1986) Ia+ murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex. Proc Natl Acad Sci USA 83:7438-42
11. Cumberbatch M, Dearman RJ, Kimber I (1997) Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology 92:388-95
12. Cunningham AL, Noble JR (1989) Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro. J Clin Invest 83:490-6
13. Fan L, Busser BW, Lifsted TQ, Oukka M, Lo D, Laufer TM (2003) Antigen presentation by keratinocytes directs autoimmune skin disease. Proc Natl Acad Sci USA 100:3386-91
14. Gaspari AA, Katz SI (1988) Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. J Immunol 140:2956-63
15. Gaspari AA, Jenkins MK, Katz SI (1988) Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. J Immunol 141:2216-20
16. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M et al. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194:769-79
17. Hemmi H, Yoshino M, Yamazaki H, Naito M, Iyoda T, Omatsu Y, et al., Kunisada T (2001) Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells. Int Immunol 13:695-704
18. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ (2005) Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23:611-20
19. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, Romani N et al. (2005) Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22:643-54
20. Koller BH, Marrack P, Kappler JW, Smithies O (1990) Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science 248:1227-30
21. Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N et al. (2006) Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24:191-201
22. Lim YS, Kang BY, Kim EJ, Kim SH, Hwang SY, Kim TS (1998) Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-gamma hybrid construct. Immunology 94:135-41
23. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P (1987) Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med 166:1654-67
24. Mayerova D, Parke EA, Bursch LS, Odumade OA, Hogquist KA (2004) Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity 21:391-400
25. Mempel TR, Henrickson SE, Von Andrian UH (2004) T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427:154-9
26. Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I et al. (2002) Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 3:1135-41
27. Merad M, Hoffmann P, Ranheim E, Slaymaker S, Manz MG, Lira SA et al. (2004) Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 10:510-7
28. Nickoloff BJ, Mitra RS, Green J, Zheng XG, Shimizu Y, Thompson C et al. (1993) Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. J Immunol 150:2148-59
29. Obhrai JS, Oberbarnscheidt M, Zhang N, Mueller DL, Shlomchik WD, Lakkis FG et al. (2008) Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol 128:1950-5
30. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH (2006) T cell-and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 7:507-16
31. Probst HC, Lagnel J, Kollias G, van den Broek M (2003) Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 18:713-20
32. Ritter U, Meissner A, Scheidig C, Korner H (2004) CD8 alpha-and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol 34:1542-50
33. Sauder DN, Carter CS, Katz SI, Oppenheim JJ (1982) Epidermal cell production of thymocyte activating factor (ETAF). J Invest Dermatol 79:34-9
34. Shibaki A, Sato A, Vogel JC, Miyagawa F, Katz SI (2004) Induction of GVHDlike skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice. J Invest Dermatol 123:109-15
35. Silberberg-Sinakin I, Thorbecke GJ, Baer RL, Rosenthal SA, Berezowsky V (1976) Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol 25:137-51
36. Silberberg-Sinakin I, Thorbecke GJ (1980) Contact hypersensitivity and Langerhans cells. J Invest Dermatol 75:61-7
37. Steinman RM, Nussenzweig MC (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99:351-8
38. Stoitzner P, Zanella M, Ortner U, Lukas M, Tagwerker A, Janke K et al. (1999) Migration of langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-alpha and IL-1beta. J Leukoc Biol 66:462-70
39. Stoitzner P, Tripp CH, Eberhart A, Price KM, Jung JY, Bursch L et al. (2006) Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci USA 103:7783-8
40. Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J et al. (2003) Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 197:153-62